NIR and Skin Cancer Margins
Primary Purpose
Non-melanoma Skin Cancer
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Near-infrared heating
Sponsored by
About this trial
This is an interventional treatment trial for Non-melanoma Skin Cancer
Eligibility Criteria
Inclusion Criteria:
The patient population includes individuals with a nonmelanotic cervicofacial cutaneous malignancy referred to a tertiary care skin cancer clinic for definitive treatment. Patients must have:
- Histologically confirmed nonmelanotic cutaneous malignancies, either basal cell or squamous cell carcinoma
- No prior treatment with investigational agents
- Ability to tolerate intended treatment Patient's age is greater than or equal to 18 years
Exclusion Criteria:
- Prior radiation therapy or photodynamic therapy to the area with the NMSC lesion
- Patients with a history of cutaneous photosensitization
- Unable to consent
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Standard of care (control)
NIR heating
Arm Description
This will be the standard of care group. The excision of the non-melanoma skin cancer will be based on standard visual inspection with 4-6mm margins.
This will be the NIR heating group, where the excision of the non-melanoma skin cancer will be based on the lesion margins based on the application of near-infrared radiation (with 4-6mm margins).
Outcomes
Primary Outcome Measures
Margin status
Difference in margin status between the control and the near-infrared heating group.
Secondary Outcome Measures
Skin vascularity changes
Visual changes in the vasculature of normal skin and NMSC skin following application or NIR light.
Full Information
NCT ID
NCT04103658
First Posted
September 23, 2019
Last Updated
September 23, 2019
Sponsor
Western University, Canada
1. Study Identification
Unique Protocol Identification Number
NCT04103658
Brief Title
NIR and Skin Cancer Margins
Official Title
Near-infrared Heating of Skin to Delineate Non-melanoma Skin Cancer Lesions: a Pilot Study.
Study Type
Interventional
2. Study Status
Record Verification Date
September 2019
Overall Recruitment Status
Unknown status
Study Start Date
September 30, 2019 (Anticipated)
Primary Completion Date
December 30, 2019 (Anticipated)
Study Completion Date
December 30, 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Western University, Canada
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
We aim to determine whether the application of near-infrared radiation via standard heat lamp to non-melanoma skin lesions (such as basal cell carcinomas) before surgical excision is able to better delineate the lesion and surgical margins. If found to do so, pre-heating of skin lesions could lead to more specimens with negative margins. Patients presenting to the tertiary care centre skin cancer clinic for excision of skin cancer will be approached and offered to participate in the study.
Detailed Description
Non-melanoma skin cancer (NMSC) is the most common cancer diagnosis in Canada, and its incidence is still increasing. Visual examination followed by biopsies of suspicious lesions are the gold standard for skin cancer diagnosis. The mainstays of treatment include photodynamic therapy, radiation therapy, and surgical excision. The margins of NMSC lesions are typically determined via visual inspection, and excised based on delineating normal from abnormal tissue. According to the National Comprehensive Cancer Network, low-risk basal cell cancers should be excised with a 4mm margin; squamous cell skin cancers and high-risk basal cell cancers should be excised with 4-6mm margins, as per the National Comprehensive Cancer Network. These lesions frequently occur on cosmetically sensitive areas of the head and neck, therefore accurate margins and excision can help to preserve the overall appearance. Accurate lesion delineation with proper margins can also reduce the need for further treatment if the margins are positive. In approximately 2-3% of cases at our centre, the margins are positive.
Near-infrared radiation (NIR) represents the light spectrum from 0.7 to 1.5 micrometers. At the shorter wavelengths, it merges with the red spectrum of visible light. These forms of light have the ability to heat the skin up to a 5 mm depth. Previous studies have examined the relationship between skin blood flow and temperature when heating skin, where dermal temperature can reach a certain peak in a defined time. Other studies have investigated the application of NIR when combined with photo immunotherapy, as a means of treating other cancers. More elaborate multispectral analysis devices have been studied for their effectiveness in diagnosing cutaneous malignancies. NIR application is well tolerated, in past studies.The objective of this study is to determine if the vasculature of normal skin and NMSC skin appears differently following heating with NIR light, and if this difference corresponds to better margin delineation.
The excisions and reconstructions are all within the standard of care. The only added testing will be application of near-infrared heat via a heating lamp to the lesional skin, for a total of ten minutes. Each patient will have their skin cancer lesion photographed, and traced onto acetate film. The NIR heating will then occur under a lamp for a total of ten minutes at a distance of 20cm. At the end of the ten minutes, the lesion and its borders will again be traced onto a separate acetate film. Using Excel for block randomization, patients will then be randomized to excision with the non-heated versus heated margins. The allocation will not be known until the moment of assignment. The excisions will then occur in the same fashion between the two groups, and all specimens will be submitted for pathology, as is standard of care.
Data will be recorded for various patient and lesions factors that may potentially influence the outcome of NIR heating therapy. These include age and gender, lesion size and location, and history of skin disorders. The lesion size and final pathology, with quantitative margin distances, will be recorded. Statistical analysis will be performed to determine if there is an overall difference in qualitative (negative or positive) and quantitative margin status between those lesions excised under standard procedure vs. NIR heating.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Non-melanoma Skin Cancer
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Masking Description
Patients will be randomly assigned to the group of excision without or with near-infrared heat. Both the patient and investigator will be aware of the group allocation prior to the definitive excision.
Allocation
Randomized
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Standard of care (control)
Arm Type
No Intervention
Arm Description
This will be the standard of care group. The excision of the non-melanoma skin cancer will be based on standard visual inspection with 4-6mm margins.
Arm Title
NIR heating
Arm Type
Experimental
Arm Description
This will be the NIR heating group, where the excision of the non-melanoma skin cancer will be based on the lesion margins based on the application of near-infrared radiation (with 4-6mm margins).
Intervention Type
Radiation
Intervention Name(s)
Near-infrared heating
Intervention Description
Same as the arm/group description. The NIR heating group will have the non-melanoma skin cancer lesion excised based on the lesion borders established from application of NIR heat at a distance of 20cm for 10 minutes.
Primary Outcome Measure Information:
Title
Margin status
Description
Difference in margin status between the control and the near-infrared heating group.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Skin vascularity changes
Description
Visual changes in the vasculature of normal skin and NMSC skin following application or NIR light.
Time Frame
3 months
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
The patient population includes individuals with a nonmelanotic cervicofacial cutaneous malignancy referred to a tertiary care skin cancer clinic for definitive treatment. Patients must have:
Histologically confirmed nonmelanotic cutaneous malignancies, either basal cell or squamous cell carcinoma
No prior treatment with investigational agents
Ability to tolerate intended treatment Patient's age is greater than or equal to 18 years
Exclusion Criteria:
Prior radiation therapy or photodynamic therapy to the area with the NMSC lesion
Patients with a history of cutaneous photosensitization
Unable to consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kiersten Pianosi, MD
Phone
519-685-8500
Ext
18074
Email
kpianosi@uwo.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Corey Moore, MD
Phone
519-685-8500
Ext
66383
Email
corey.moore@sjhc.london.on.ca
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
NIR and Skin Cancer Margins
We'll reach out to this number within 24 hrs